Augusta, GA5 Active Studies

Sickle Cell Disease Clinical Trials in Augusta, GA

Find 5 actively recruiting sickle cell disease clinical trials in Augusta, GA. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
987
Enrolling

Recruiting Sickle Cell Disease Studies in Augusta

NCT06385886Recruiting

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer ...

Augusta, GA500 participantsRTI International
View Study Details
NCT06439082Recruiting

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide ther...

Augusta, GAPHASE3315 participantsNovartis Pharmaceuticals
View Study Details
NCT04657822Recruiting

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

This is a multi-center multi-national rollover study to allow continued access to crizanlizumab for patients with sickle cell disease (SCD) who are on crizanlizumab treatment in a Novartis-sponsored s...

Augusta, GAPHASE4130 participantsNovartis Pharmaceuticals
View Study Details
NCT07187973Recruiting

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

This is an open-label, multicenter, within-participant dose-escalation study examining up to 3 dose levels of DISC-3405 and will assess the safety, tolerability, PK, and PD of DISC 3405 in participant...

Augusta, GAPHASE124 participantsDisc Medicine, Inc
View Study Details
NCT01245179Recruiting

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

The goal of this clinical research study is to find out about the safety and effects of a drug called panobinostat when given to adults with sickle cell disease. Panobinostat is a pan histone deacetyl...

Augusta, GAPHASE118 participantsAbdullah Kutlar
View Study Details

About Sickle Cell Disease Clinical Trials in Augusta

Sickle cell disease is a group of inherited blood disorders where abnormal hemoglobin causes red blood cells to become rigid and sickle-shaped. It causes pain crises, organ damage, and shortened life expectancy. Treatment includes hydroxyurea, blood transfusions, and gene therapy.

There are currently 5 sickle cell disease clinical trials recruiting participants in Augusta, GA. These studies are seeking a combined 987 participants. Research is being sponsored by RTI International, Novartis Pharmaceuticals, Disc Medicine, Inc and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sickle Cell Disease Clinical Trials in Augusta — FAQ

Are there sickle cell disease clinical trials in Augusta?

Yes, there are 5 sickle cell disease clinical trials currently recruiting in Augusta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Augusta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.

Are clinical trials in Augusta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.

What sickle cell disease treatments are being tested?

The 5 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for sickle cell disease.

Data updated July 21, 2026 from ClinicalTrials.gov